Journal of Clinical Oncology

PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer

F Fabio Turco (Fabio Turco, MD, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland; Silke Gillessen, MD, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland, Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland; and Bertrand Tombal, MD, Division of Urology, Clinique Universitaire St Luc, Brussels, Belgium) S Silke Gillessen (Oncology Institute of Southern Switzerland, Bellinzona, Switzerland) B Bertrand Tombal
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 1, Issue 1
Published July 09, 2026
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

F

Fabio Turco

Fabio Turco, MD, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland; Silke Gillessen, MD, Oncology Institute of Southern Switzerland (IOSI), Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland, Faculty of Biosciences, Università della Svizzera Italiana, Lugano, Switzerland; and Bertrand Tombal, MD, Division of Urology, Clinique Universitaire St Luc, Brussels, Belgium

S

Silke Gillessen

Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

B

Bertrand Tombal

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001